GOLIMUMAB — all Canadian products
13 DINs
13 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is GOLIMUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02559560 | LIVMOTY | JANSSEN INC | Solution | Subcutaneous | GOLIMUMAB 50 MG | Approved | |
| 02559536 | LIVMOTY | JANSSEN INC | Solution | Subcutaneous | GOLIMUMAB 100 MG | Approved | |
| 02559544 | LIVMOTY | JANSSEN INC | Solution | Subcutaneous | GOLIMUMAB 100 MG | Approved | |
| 02559552 | LIVMOTY | JANSSEN INC | Solution | Subcutaneous | GOLIMUMAB 50 MG | Approved | |
| 02324776 | SIMPONI | JANSSEN INC | Solution | Subcutaneous | GOLIMUMAB 50 MG | Marketed | |
| 02324784 | SIMPONI | JANSSEN INC | Solution | Subcutaneous | GOLIMUMAB 50 MG | Marketed | |
| 02413175 | SIMPONI | JANSSEN INC | Solution | Subcutaneous | GOLIMUMAB 100 MG | Marketed | |
| 02413183 | SIMPONI | JANSSEN INC | Solution | Subcutaneous | GOLIMUMAB 100 MG | Marketed | |
| 02417472 | SIMPONI I.V. | JANSSEN INC | Solution | Intravenous | GOLIMUMAB 50 MG | Marketed | |
| 02567393 | UPGOLYV | JAMP PHARMA CORPORATION | Solution | Subcutaneous | GOLIMUMAB 50 MG | Approved | |
| 02567407 | UPGOLYV | JAMP PHARMA CORPORATION | Solution | Subcutaneous | GOLIMUMAB 100 MG | Approved | |
| 02567415 | UPGOLYV | JAMP PHARMA CORPORATION | Solution | Subcutaneous | GOLIMUMAB 100 MG | Approved | |
| 02567423 | UPGOLYV | JAMP PHARMA CORPORATION | Solution | Subcutaneous | GOLIMUMAB 50 MG | Approved |
Browse other molecules: